Table 2.
One-year outcomes in various subsets of patients with pulmonary hypertension. PAH = Pulmonary arterial hypertension, PVH = Pulmonary venous hypertension, LD-PH = Lung disease associated pulmonary hypertension, CTEPH = Chronic thromboembolic pulmonary hypertension, PH-Misc = Pulmonary hypertension due to miscellaneous causes.
| Total (n = 2003) | PAH (n = 317) | PVH (n = 1294) | LD-PH (n = 293) | CTEPH (n = 73) | PH-Misc (n = 26) | ||
|---|---|---|---|---|---|---|---|
| Primary endpoint, n(%) | 182 (9.1) | 8 (2.5) | 139 (10.7) | 29 (9.9) | 3 (4.1) | 3 (11.5) | p < 0.001 |
| Death, n(%) | 83 (4.1) | 6 (1.9) | 53 (4.1) | 19 (6.5) | 2 (2.7) | 3 (11.5) | |
| Heart failure, n (%) | 103 (5) | 2 (0.6) | 90 (7) | 10 (3.4) | 1 (1.4) | 0 | |
| Hospitalization events, n (%) | 1235 (61.7) | 196 (61.8) | 807 (62.4) | 177 (60.4) | 40 (54.8) | 15 (57.7) | p = 0.718 |